Setting the New Standard
at AAIC 2025

Discover how Standard BioTools is advancing neurodegeneration research through precision proteomics.

Booth 834 l July 27–31

 

Advancing discovery through precision proteomics

We’re setting the new standard for protein analysis, enabling researchers worldwide to unlock critical insights into Alzheimer’s disease, dementia and other neurodegenerative conditions with unprecedented scale and precision. Our innovative platforms empower the scientific community to decode complex protein networks, identify novel biomarkers and accelerate the path from discovery to therapeutic breakthroughs.

Don’t miss our Product Theater

Uncovering Protein Biology of Neurodegeneration
at Scale:
What the Global Neurodegeneration Proteomics Consortium Has Learned (so far) from SomaScan Proteomics Across Multiple Cohorts

Speakers

 • Farhad Imam, Gates Ventures
 • Clare Paterson, StandardBioTools
 • Jacob Vogel, Lund University

Tuesday, July 29 l 1:05–1:45 pm
Stage #2 (in front of aisle 1600 in the exhibit hall)

Reserve Your Seat

Uncovering Protein Biology of Neurodegeneration at Scale: What the Global Neurodegeneration Proteomics Consortium Has Learned (so far) from SomaScan Proteomics Across Multiple Cohorts

Speakers
Farhad Imam and Varsha Krish, Gates Ventures

Tuesday, July 29 l 1:05–1:45 pm
Stage #2 (in front of aisle 1,600 in the exhibit hall)

Reserve Your Seat

What to expect from the session

The Global Neurodegeneration Proteomics Consortium (GNPC) represents a groundbreaking public-private partnership that has assembled one of the world’s largest SomaScan™ Assay proteomic datasets. This product feature will showcase transformative findings from the GNPC, including:

  • Discovery of novel protein signatures for predicting major forms of dementia and neurodegenerative conditions
  • Identification of multiple underlying pathologies through comprehensive protein profiling
  • Mechanistic insights derived from complex protein network analysis
  • Large-scale proteomic findings across diverse patient cohorts

Visit our booth

Discover the future of proteomic research. Stop by our booth to explore how Standard BioTools™ proteomic solutions can accelerate your neurodegeneration research. Our team of experts will be on hand to demonstrate:

  • Case studies showcasing breakthrough discoveries in neurodegeneration
  • Personalized consultations on integrating proteomics into your research pipeline

Whether you’re focused on biomarker discovery, drug target identification or unraveling disease mechanism pathways, connect with our scientists to discover how our solutions can accelerate your research and support your next breakthrough.

Learn more about dementia risk following weight loss in type 2 diabetes
at our poster session

Monday, July 28 from 7:30 am–4:15 pm (poster #108444)

Using proteomics to advance understanding of Alzheimer’s disease

View webinar

 

Defining standards

Our industry-leading proteomic and multi-omic solutions that scale

CyTOF Logo

Every marker, all at once

Our industry-leading proteomic and multi-omic solutions that scale

Learn more

Hyperion Logo

High-resolution spatial proteomics

Highest dynamic range and throughput

Learn more

SomaScan Logo

Ultrahigh-plex precision proteomics

Enable 11,000 protein measurements with unparalleled reproducibility

Learn more

Abstract cell with Standard BioTools product callouts

Interested in talking with an expert?

Connect with us

For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2025 Standard BioTools Inc. All rights reserved.